Century secures $60m in stock sale and buys preclinical cell therapy biotech
Share this article Century plans to use the proceeds from the private placement to fund the expansion of the clinical development of its lead candidate,
Share this article Century plans to use the proceeds from the private placement to fund the expansion of the clinical development of its lead candidate,
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian here
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal
Understanding the mutation and evolution of viruses (such as SARS-CoV-2) is crucial for effective public health management and response.
While debating the pros and cons of robotically assisted lung transplantation, Albert Jauregui, MD, PhD told attendees at the Annual Meeting and Scientific Sessions of
The association between media use among adolescents and the occurrence of psychotic experiences.
LONDON — Following a nine-month investigation, European regulators said Friday they have found no evidence that GLP-1 drugs like Ozempic and Wegovy cause suicidal thoughts
Nearly a quarter of adults disenrolled from Medicaid in the past year say they are now uninsured, according to a survey released Friday that details
Thirty years after prisoners with disabilities sued the state of California and 25 years after a federal court first ordered accommodations, a judge found that
Regina Barrett, a 69-year-old retiree who lives in this small North Carolina city southeast of Charlotte, has not been happy with her tap water for